Current Neuropharmacology
Volume 17, 12 Issues, 2019
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
ISSN: 1875-6190 (Online)
ISSN: 1570-159X (Print)
This journal supports open access
Ranking and Category
-
69th of 261 in
Neurosciences
-
40th of 261 in
Pharmacology & Pharmacy
Aims & Scope
Current Neuropharmacology aims to provide current, comprehensive/mini reviews and guest edited issues of all areas of neuropharmacology and related matters of neuroscience. The reviews cover the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience.
The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.
Current Neuropharmacology
,Volume 17
-Number 5
Biography Open Access
Meet Our Editorial Board Member
, 17(5): 403Albert Fernández Teruel
DOI: 10.2174/1570159X1705190405151423
Meet Our Editorial Board Member
Perspective Open Access
The Forgotten Cells: Role of Astrocytes in Mood Disorders During the Aging
, 17(5): 404 - 405P. Sampedro-Piquero* and R.D. Moreno-Fernandez
DOI: 10.2174/1570159X1705190405151808
The Forgotten Cells: Role of Astrocytes in Mood Disorders During the Aging
Review Article
Supplementation with Curcuma longa Reverses Neurotoxic and Behavioral Damage in Models of Alzheimer’s Disease: A Systematic Review
, 17(5): 406 - 421Ianara Mendonça da Costa, Marco Aurelio de Moura Freire, José Rodolfo Lopes de Paiva Cavalcanti, Dayane Pessoa de Araújo, Bianca Norrara, Isleânia Maria Marques Moreira Rosa, Eduardo Pereira de Azevedo, Amalia Cinthia Meneses do Rego, Irami Araújo Filho and Fausto Pierdoná Guzen*
DOI: 10.2174/0929867325666180117112610
Supplementation with Curcuma longa Reverses Neurotoxic and Behavioral Damage in Models of Alzheimer’s Disease: A Systematic Review
Review Article
Functional Cross-Talk between Adenosine and Metabotropic Glutamate Receptors
, 17(5): 422 - 437David Agustin León-Navarro, José Luis Albasanz and Mairena Martín*
DOI: 10.2174/1570159X16666180416093717
Functional Cross-Talk between Adenosine and Metabotropic Glutamate Receptors
Review Article
Insights Into the Molecular Aspects of Neuroprotective Bacoside A and Bacopaside I
, 17(5): 438 - 446Vini C. Sekhar, Gayathri Viswanathan and Sabulal Baby*
DOI: 10.2174/1570159X16666180419123022
Insights Into the Molecular Aspects of Neuroprotective Bacoside A and Bacopaside I
Review Article
Closed-loop Neuropharmacology for Epilepsy: Distant Dream or Future Reality?
, 17(5): 447 - 458Irene Aicua-Rapun*, Pascal André and Jan Novy
DOI: 10.2174/1570159X16666180308154646
Closed-loop Neuropharmacology for Epilepsy: Distant Dream or Future Reality?
Review Article
Role of Estradiol in the Expression of Genes Involved in Serotonin Neurotransmission: Implications for Female Depression
, 17(5): 459 - 471Olivia Tania Hernández-Hernández, Lucía Martínez-Mota*, José Jaime Herrera-Pérez and Graciela Jiménez-Rubio
DOI: 10.2174/1570159X16666180628165107
Role of Estradiol in the Expression of Genes Involved in Serotonin Neurotransmission: Implications for Female Depression
Review Article
Therapeutic Potential of Multifunctional Tacrine Analogues
, 17(5): 472 - 490Maja Przybyłowska, Szymon Kowalski, Krystyna Dzierzbicka and Iwona Inkielewicz-Stepniak*
DOI: 10.2174/1570159X16666180412091908
Therapeutic Potential of Multifunctional Tacrine Analogues
Articles Ahead of Print
Drug Treatment of Trichotillomania (Hair-pulling Disorder), Excoriation (Skin-picking) Disorder, and Nail-biting (Onychophagia)
Gabriele Sani*, Ida Gualtieri, Marco Paolini, Luca Bonanni, Edoardo Spinazzola, Matteo Maggiora, Vito Pinzone, Roberto Brugnoli, Gloria Angeletti, Paolo Girardi, Chiara Rapinesi and Georgios D. Kotzalidis
View Abstract View on PubMed
NLRP3 Inflammasome in the Pathophysiology of Hemorrhagic Stroke: A Review
Yujie Luo, Cesar Reis and Sheng Chen*
View Abstract View on PubMed
Association between Serum Lipids and Antipsychotic Response in Schizophrenia
David D. Kim, Alasdair M. Barr, Diane H. Fredrikson, William G. Honer and Ric M. Procyshyn*
View Abstract View on PubMed
Systematic Review of Food Addiction as Measured with the Yale Food Addiction Scale: Implications for the Food Addiction Construct
Louise Penzenstadler*, Carina Soares, Laurent Karila and Yasser Khazaal
View Abstract View on PubMed
Calpain-1 and Calpain-2 in the Brain: Dr. Jekill and Mr Hyde?
Michel Baudry*
View Abstract View on PubMed
Pharmacotherapy for Hoarding Disorder: How did the Picture Change since its Excision from OCD?
Daria Piacentino*, Massimo Pasquini , Gabriele Sani, Chiara Chetoni, Simone Cappelletti and Georgios D. Kotzalidis
View Abstract View on PubMed
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences
Michele Romoli, Petra Mazzocchetti, Renato D’Alonzo, Sabrina Siliquini, Victoria Elisa Rinaldi, Alberto Verrotti, Paolo Calabresi and Cinzia Costa*
View Abstract View on PubMed
Why Should Psychiatrists and Neuroscientists Worry about Paraoxonase 1?
Estefania Gastaldello Moreira*, Karine Maria Boll, Dalmo Guilherme Correia, Janaina Favaro Soares, Camila Rigobello and Michael Maes
View Abstract View on PubMed
Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD)
Antonio Del Casale*, Serena Sorice, Alessio Padovano, Maurizio Simmaco, Stefano Ferracuti, Dorian A. Lamis, Chiara Rapinesi, Gabriele Sani, Paolo Girardi, Georgios D. Kotzalidis and Maurizio Pompili
View Abstract View on PubMed
Potential metabolic and behavioural roles of the putative endocannabinoid receptors GPR18, GPR55 and GPR119 in feeding
Ricardo E. Ramírez-Orozco, Ricardo García-Ruiz, Paula Morales, Carlos M. Villalón, J. Rafael Villafán-Bernal and Bruno A. Marichal-Cancino*
View Abstract
Abstracts Ahead of Print
Monoamines and their derivatives on GPCRs: potential therapy for Alzheimer’s Disease
Eunice D. Farfán-García, Ricardo Gómez-Marques, Mónica Barrón-González, Teresa Pérez-Capistran, Martha C. Rosales-Hernández, Rodolfo Pinto-Almazán and Marvin A. Soriano-Ursúa*
View Abstract
Using Cell Cultures for the Investigation of Treatments for Attention Deficit Hyperactivity Disorder: Systematic Review
D. Chierrito, J. C. P. Mello*, C. B. Villas-Boas, F. S. Tonin, F. Fernandez-Llimos and A. C. C. Sanches
View Abstract
Brain Stimulation in Obsessive-Compulsive Disorder (OCD): A Systematic Review
Chiara Rapinesi*, Georgios D. Kotzalidis, Stefano Ferracuti, Gabriele Sani, Paolo Girardi and Antonio Del Casale
View Abstract
Far-infrared ray-mediated antioxidant potentials are important for attenuating psychotoxic disorders
Naveen Sharma , Eun-Joo Shin, Nam Hun Kim , Eun-Hee Cho, Bao Trong Nguyen, Ji Hoon Jeong , Choon Gon Jang , Seung-Yeol Nah and Hyoung-Chun Kim*
View Abstract
Placebo effect in Obsessive-Compulsive Disorder (OCD). Placebo response and placebo responders in OCD: The trend over time
Georgios D. Kotzalidis*, Antonio Del Casale, Maurizio Simmaco, Lucia Pancheri, Roberto Brugnoli, Marco Paolini, Ida Gualtieri, Stefano Ferracuti, Valeria Savoja, Ilaria Cuomo, Lavinia De Chiara, Alessio Mosca, Gabriele Sani, Paolo Girardi, Maurizio Pompili, Chiara Rapinesi and on behalf of the Sapienza Group for the Study of the Placebo Effect in Psychiatric Disorders
View Abstract
Editor's Choice
Functional Cross-Talk between Adenosine and Metabotropic Glutamate Receptors
, 2019; 17(5): 422 - 437David Agustín León-Navarro, José Luis Albasanz and Mairena Martín*
DOI: 10.2174/1570159X16666180416093717
NGF and BDNF Alterations by Prenatal Alcohol Exposure
, 2019; 17(4): 308 - 317Valentina Carito, Mauro Ceccanti, Giampiero Ferraguti, Roberto Coccurello, Stefania Ciafrè, Paola Tirassa and Marco Fiore*
DOI: 10.2174/1570159X15666170825101308
Current Drugs and Potential Future Neuroprotective Compounds for Parkinson’s Disease
, 2019; 17(3): 295 - 306Iván Carrera* and Ramón Cacabelos
DOI: 10.2174/1570159X17666181127125704
Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer’s Disease
, 2019; 17(2): 176 - 183Giuseppina Talarico*, Alessandro Trebbastoni, Giuseppe Bruno and Carlo de Lena
DOI: 10.2174/1570159X16666180702144644
Statins and the Brain: More than Lipid Lowering Agents?
, 2019; 17(1): 59 - 83Anna Fracassi , Martina Marangoni, Pamela Rosso, Valentina Pallottini, Marco Fioramonti, Silvia Siteni and Marco Segatto*
DOI: 10.2174/1570159X15666170703101816
Nerve Growth Factor: Early Studies and Recent Clinical Trials
, 2018; 16(10): 1455 - 1465Maria Luisa Rocco, Marzia Soligo, Luigi Manni and Luigi Aloe*
DOI: 10.2174/1570159X16666180412092859
Cell Death Mechanisms in Stroke and Novel Molecular and Cellular Treatment Options
, 2018; 16(9): 1396 - 1415Emine Sekerdag*, Ihsan Solaroglu and Yasemin Gursoy-Ozdemir
DOI: 10.2174/1570159X16666180302115544
Oxytocin and Eating Disorders: A Narrative Review on Emerging Findings and Perspectives
, 2018; 16(8): 1111 - 1121Katrin Giel, Stephan Zipfel and Manfred Hallschmid*
DOI: 10.2174/1570159X15666171128143158
Modulation of the Immune System for the Treatment of Glaucoma
, 2018; 16(7): 942 - 958Katharina Bell, Nadine von Thun und Hohenstein-Blaul, Julia Teister and Franz Grus*
DOI: 10.2174/1570159X15666170720094529
Impact of Dietary Fats on Brain Functions
, 2018; 16(7): 1059 - 1085Rosanna Chianese, Roberto Coccurello, Andrea Viggiano, Marika Scafuro, Marco Fiore, Giangennaro Coppola, Francesca Felicia Operto, Silvia Fasano, Sophie Laye, Riccardo Pierantoni and Rosaria Meccariello*
DOI: 10.2174/1570159X15666171017102547
Open Access Articles
Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness
, 2019; 17(2): 108 - 128Jonathan Hamill, Jaime Hallak, Serdar M. Dursun and Glen Baker*
Relevance of CYP2C9 Function in Valproate Therapy
, 2019; 17(1): 99 - 106Katalin Monostory*, Andrea Nagy, Katalin Tóth, Tamás Bűdi , Ádám Kiss, Máté Déri and Gábor Csukly
Why Should Psychiatrists and Neuroscientists Worry about Paraoxonase 1?
, 2019; 17: 1 - 17 (E-Pub Ahead of Print)Estefania Gastaldello Moreira*, Karine Maria Boll, Dalmo Guilherme Correia, Janaina Favaro Soares, Camila Rigobello and Michael Maes
Mst1: Function and Mechanism in Brain and Myocardial Ischemia Reperfusion Injury
, 2018; 16(9): 1358 - 1364Di Li, Haibo Ni, Qin Rui, Rong Gao* and Gang Chen
The Role of IRE1 Signaling in the Central Nervous System Diseases
, 2018; 16(9): 1340 - 1347Haibo Ni, Qin Rui, Di Li*, Rong Gao and Gang Chen
Mean Diffusivity in the Dopaminergic System and Neural Differences Related to Dopaminergic System
, 2018; 16(4): 460 - 474Hikaru Takeuchi* and Ryuta Kawashima
Does Ceruloplasmin Defend Against Neurodegenerative Diseases?
, 2018; 16: 1 - 10 (E-Pub Ahead of Print)Bo Wang and Xiao-Ping Wang*
Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets
, 2016; 14(7): 721 - 731Ji-chun Zhang, Wei Yao and Kenji Hashimoto
Animal Models of Maternal Immune Activation in Depression Research
, 2016; 14(7): 688 - 704Marianne Ronovsky, Stefanie Berger, Barbara Molz, Angelika Berger and Daniela D. Pollak
Current Therapy of Drugs in Amyotrophic Lateral Sclerosis
, 2016; 14(4): 314 - 321Haiyan Lu, Wei Dong Le, Ya-Ying Xie and Xiao-Ping Wang
Drug Therapy for Behavioral and Psychological Symptoms of Dementia
, 2016; 14(4): 307 - 313Feng Wang, Ting-Yi Feng, Shilin Yang, Maurice Preter, Jiang-Ning Zhou and Xiao-Ping Wang
Freezing of Gait in Parkinsonism and its Potential Drug Treatment
, 2016; 14(4): 302 - 306Li-Li Zhang, S. Duff Canning and Xiao-Ping Wang
Neuroleptic Malignant Syndrome: A Review from a Clinically Oriented Perspective
, 2015; 13(3): 395 - 406Lurdes Tse, Alasdair M. Barr, Vanessa Scarapicchia and Fidel Vila-Rodriguez
cGMP Signaling, Phosphodiesterases and Major Depressive Disorder
, 2011; 9(4): 715 - 727Gillian W. Reierson, Shuyu Guo, Claudio Mastronardi, Julio Licinio and Ma-Li Wong
Most Cited Articles
Alzheimer's disease: Targeting the Cholinergic System
, 2016; 14(1): 101-115.Talita H. Ferreira-Vieira, Isabella M. Guimaraes, Flavia R. Silva and Fabiola M. Ribeiro
DOI: 10.2174/1570159X13666150716165726
Brain-derived Neurotrophic Factor (BDNF)-TrkB Signaling in Inflammation-related Depression and Potential Therapeutic Targets
, 2016; 14(7): 721-731.Ji-chun Zhang, Wei Yao and Kenji Hashimoto
DOI: 10.2174/1570159X14666160119094646
Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration
, 2016; 14(1): 55-71.Shabir Ahmad Ganai, Mahalakshmi Ramadoss and Vijayalakshmi Mahadevan
DOI: 10.2174/1570159X13666151021111609
Inflammation in Depression and the Potential for Anti-Inflammatory Treatment
, 2016; 14(7): 732-742.Ole Kohler, Jesper Krogh, Ole Mors and Michael Eriksen Benros
DOI: 10.2174/1570159X14666151208113700
Mechanisms by which Stress Affects the Experimental and Clinical Inflammatory Bowel Disease (IBD): Role of Brain-Gut Axis
, 2016; 14(8): 892-900.Bartosz Brzozowski, Agnieszka Mazur-Bialy, Robert Pajdo, Slawomir Kwiecien, Jan Bilski, Malgorzata Zwolinska-Wcislo, Tomasz Mach and Tomasz Brzozowski
DOI: 10.2174/1570159X14666160404124127
Mitochondrial Biology and Neurological Diseases
, 2016; 14(2): 143-154.Siddharth Arun, Lei Liu and Gizem Donmez
DOI: 10.2174/1570159X13666150703154541
LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson’s Disease, Where Do We Stand?
, 2016; 14(3): 214-225.Jean-Marc Taymans and Elisa Greggio
DOI: 10.2174/1570159X13666151030102847
Molecular and Cellular Mechanisms of Rapid-Acting Antidepressants Ketamine and Scopolamine
, 2017; 15(1): 11-20.Eric S. Wohleb, Danielle Gerhard, Alex Thomas and Ronald S. Duman
DOI: 10.2174/1570159X14666160309114549
Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment
, 2016; 14(7): 674-687.Frank M. Schmidt, Kenneth C. Kirkby and Nicole Lichtblau
DOI: 10.2174/1570159X14666160115130414
Most Accessed Articles
Cell Death Mechanisms in Stroke and Novel Molecular and Cellular Treatment Options
, 2018; 16(9): 1396-1415.Emine Sekerdag*, Ihsan Solaroglu and Yasemin Gursoy-Ozdemir
DOI: 10.2174/1570159X16666180302115544
Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness
, 2019; 17(2): 108-128.Jonathan Hamill, Jaime Hallak, Serdar M. Dursun and Glen Baker*
DOI: 10.2174/1570159X16666180125095902
Aminopyridines and Acetyl-DL-leucine: New Therapies in Cerebellar Disorders
, 2019; 17(1): 7-13.Roger Kalla and Michael Strupp*
DOI: 10.2174/1570159X16666180905093535
Nerve Growth Factor: Early Studies and Recent Clinical Trials
, 2018; 16(10): 1455-1465.Maria Luisa Rocco, Marzia Soligo, Luigi Manni and Luigi Aloe*
DOI: 10.2174/1570159X16666180412092859
Opioid Antagonists for Pharmacological Treatment of Gambling Disorder: Are they Relevant?
, 2018; 16(10): 1418-1432.Caroline Victorri-Vigneau*, Andrew Spiers, Pascal Caillet, Mélanie Bruneau, IGNACE-consortium, Gaëlle Challet-Bouju and Marie Grall-Bronnec
DOI: 10.2174/1570159X15666170718144058
Oxytocin and Eating Disorders: A Narrative Review on Emerging Findings and Perspectives
, 2018; 16(8): 1111-1121.Katrin Giel, Stephan Zipfel and Manfred Hallschmid*
DOI: 10.2174/1570159X15666171128143158
The Role of IRE1 Signaling in the Central Nervous System Diseases
, 2018; 16(9): 1340-1347.Haibo Ni, Qin Rui, Di Li*, Rong Gao and Gang Chen
DOI: 10.2174/1570159X16666180416094646
Experimental Models for Aging and their Potential for Novel Drug Discovery
, 2018; 16(10): 1466-1483.Jaume Folch, Oriol Busquets, Miren Ettcheto, Elena Sánchez-López, Mercè Pallàs, Carlos Beas-Zarate, Miguel Marin, Gemma Casadesus, Jordi Olloquequi, Carme Auladell and Antoni Camins*
DOI: 10.2174/1570159X15666170707155345
P2X7 Receptor-Associated Programmed Cell Death in the Pathophysiology of Hemorrhagic Stroke
, 2018; 16(9): 1282-1295.Hengli Zhao, Yujie Chen* and Hua Feng
DOI: 10.2174/1570159X16666180516094500
Immune-mediated Cerebellar Ataxias: Practical Guidelines and Therapeutic Challenges
, 2019; 17(1): 33-58.Hiroshi Mitoma*, Mario Manto and Christiane S. Hampe
DOI: 10.2174/1570159X16666180917105033
  |
Editor-in-Chief
T.E. Salt
University College London
Institute of Ophthalmology
London EC1V9EL
UK
University College London
Institute of Ophthalmology
London EC1V9EL
UK
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Neuropharmacology was introduced in 2003 with the assistance of Dr. T.E. Salt, who is the current acting Editor-in-Chief since 2003.
Scopus CiteScore Metrics: 4.28
New eBook
 |
Neurobiology of Mood DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Webmaster Contact: info@benthamscience.net